<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Microbiology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>16</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>06</Month>
        <Day>19</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Immunogenicity of mannan derived from Mycobacterium bovis as a promising adjuvant in vaccine BCG</title>
    <FirstPage>351</FirstPage>
    <LastPage>356</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Rajab</FirstName>
        <LastName>Mardani</LastName>
        <affiliation locale="en_US">Department of Viral Vaccines, Research and Production Complex, Pasteur Institute of  Iran, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ariana</FirstName>
        <LastName>Alavi</LastName>
        <affiliation locale="en_US">Department of Production, Bsc in Biotechnology Pharmaceutical and Drug Delivery System Labratoary, Pasteur Institute of Iran, Tehren, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Dawood</FirstName>
        <LastName>Mousavi Nasab</LastName>
        <affiliation locale="en_US">Department of Arboviruses and Viral Hemorrhagic Fevers (National Ref Lab), Pasteur Institute of Iran, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nayebali</FirstName>
        <LastName>Ahmadi</LastName>
        <affiliation locale="en_US">Proteomics Research Center, Department of Medical Lab Technology, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Javad</FirstName>
        <LastName>Hossein Tehrani</LastName>
        <affiliation locale="en_US">Department of Clinical Biochemistry, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Shahali</LastName>
        <affiliation locale="en_US">Department of Viral Vaccines, Research and Production Complex, Pasteur Institute of  Iran, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Delaram</FirstName>
        <LastName>Doroud</LastName>
        <affiliation locale="en_US">Department of Production, Research and Production Complex, Pasteur Institute of Iran, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>02</Month>
        <Day>21</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>05</Month>
        <Day>05</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: Lipoarabinomannan is one of the components of the significant structural cell surfaces of mycobacteria and serves as an immunostimulatory factor. TNF-&#x3B1; and IL-12 are two examples of the anti-bacterial inflammatory cytokines that are activated and induced during infection.
Materials and Methods: In this study, mannan was extracted and processed, and then Bulb/c female mice were used in three groups, one group was given BCG vaccine, the other group was given BCG vaccine with mannan adjuvant, and a non-injected group was used as a control group. Inflammatory factors interleukin-12, TNF-&#x3B1;, IgG and IgM were measured in mouse serum.
Results: The levels of the inflammatory factors interleukin-12 and TNF-&#x3B1; in the serum isolated from mice receiving the BCG vaccine with mannan adjuvant showed a significant difference compared to the group that received only the BCG vaccine and the control group [IL-12] and , with P&#x2264;0.05.The examination of the level of IgG immune factors in these three groups revealed a significant difference. The group that received the BCG vaccine with mannan adjuvant showed a marked contrast compared to the group that received only the BCG vaccine and the control group, with P&#x2264;0.05. The level of IgM was higher in the group that received the BCG vaccine alone compared to the adjuvant vaccine group and the control group, with P&#x2264;0.05.
Conclusion: Our results indicated that mice receiving the BCG vaccine with mannan adjuvant had significantly higher serum levels of IL-12, TNF-&#x3B1;, and IgG than the group receiving BCG alone.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/4620</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/4620/1676</pdf_url>
  </Article>
</Articles>
